Summary
To determine the role of epidermal growth factor (EGF) receptors in thyroid tumorigenesis, EGF binding was compared in membranes from malignant and from benign thyroid tumors. Surgical specimens were obtained from 28 patients with thyroid carcinomas (3 papillary, 13 follicular, 6 undifferentiated, and 6 medullary carcinomas) and from 30 patients with benign thyroid tumors (15 scintigraphically functional and 15 nonfunctional nodules). In 30 cases normal tissue adjacent to the tumor was also obtained. EGF binding was seen to be increased not only in thyroid carcinomas but also in benign thyroid tumors, particularly in functional thyroid adenomas. The highest EGF binding was found in undifferentiated carcinomas. A direct comparison of the EGF binding characteristics in tumor and adjacent normal thyroid tissue revealed that the increased binding of EGF is due mainly to an increase in the number of binding sites rather than an alteration in receptor affinities. EGF binding capacities were 18.4±16.7 fmol/mg protein in thyroid carcinomas and 10.5±5.2 fmol/mg in the corresponding normal tissue (P<0.05, K d 0.84±0.26 nM, n=11). In autonomously functioning thyroid adenomas binding capacities were 14.2±8.2 fmol/mg in the nodules and 8.9±4.8 fmol/mg in normal tissue (P < 0.01, K d 0.73±0.62 nM, n = 15). In conclusion, EGF receptor levels are increased not only in malignant thyroid tumors but also in well-differentiated benign thyroid nodules. The data indicate that an increased expression of EGF receptors, although likely to be important in the regulation of thyroid growth in vivo, is not by itself associated with malignant cell transformation and loss of differentiated function.
Similar content being viewed by others
Abbreviations
- EGF:
-
epidermal growth factor
- EGFr:
-
epidermal growth factor receptor
- TGF-α:
-
transforming growth factor-α
References
Aasland R, Akslen LA, Varhaug JE, Lillehaug JR (1990) Co-expression of the genes encoding transforming growth factor-alpha and its receptor in papillary carcinomas of the thyroid. Int J Cancer 46:382–387
Bidey SP, Tomlinson S (1988) The regulation and integration of thyroid follicular differentiation and function. Clin Endocrinol (Oxf) 28:423–444
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:255–259
Duh QY, Gum ET, Gerend PL, Raper SE, Clark OH (1985) Epidermal growth factor receptors in normal and neoplastic thyroid tissue. Surgery 98:1000–1007
Duh QY, Siperstein AE, Miller RA, Sancho JJ, Demeure MJ, Clark OH (1990) Epidermal growth factor receptors and adenylate cyclase activity in human thyroid tissues. World J Surg 14:410–417
Frauman AG, Moses AC (1990) Oncogenes and growth factors in thyroid carcinogenesis. Endocrinol Metab Clin North Am 19:479–493
Gärtner R (1992) Thyroid growth in vitro. Exp Clin Endocrinol 100:32–35
Hendler FJ, Ozanne BW (1984) Human squamous cell lung cancers express increased epidermal growth factor receptors. J Clin Invest 74:647–651
Hirata Y, Orth DN (1979) Epidermal growth factor (urogastrone) in human tissues. J Clin Endocrinol Metab 48:667–672
Humphries H, Mac Neil S, Munro DS, Tomlinson S (1984) Interaction of epidermal growth factor with receptors on human and porcine thyroid membranes. J Endocrinol 102:57–61
Kajikawa K, Yasui W, Sumiyoshi H, Yoshida K, Nakayama H, Ayhan A, Yokozaki H, Ito H (1991) Expression of epidermal growth factor in human tissues. Virchows Arch [A] 418:27–32
Kanamori A, Abe Y, Yajima Y, Manabe Y, Ito K (1989) Epidermal growth factor receptors in plasma membranes of normal and diseased human thyroid glands. J Clin Endocrinol Metab 68:899–903
Kasai K, Kuroda H, Hashigami Y, Ishikawa M, Nakamura T, Shimoda SI (1985) Specific epidermal growth factor receptors on porcine and human thyroid membranes. Horm Metab Res 17:592–594
Kasai K, Hiraiwa M, Suzuki Y, Emoto T, Banba N, Nakamura T, Shimoda SI (1987) Presence of epidermal growth factor receptors on human thyroid membranes. Acta Endocrinol (Copenh) 114:396–401
Lemoine NR, Hughes CM, Gullick WJ, Brown CL, Wynford-Thomas D (1991) Abnormalities of the EGF receptor system in human thyroid neoplasia. Int J Cancer 49:558–561
Maekinen T, Pekonen F, Franssila K, Lamberg BA (1988) Receptors for epidermal growth factor and thyrotropin in thyroid carcinoma. Acta Endocrinol (Copenh) 117:45–50
Miyamoto M, Sugawa H, Mori T, Hase K, Kuma K, Imura H (1988) Epidermal growth factor receptors on cultured neoplastic human thyroid cells and effects of epidermal growth factor and thyroid-stimulating hormone on their growth. Cancer Res 48:3652–3656
Munson PJ, Rodbard D (1980) LIGAND: a versatile computerized approach for characterization of ligand-bindingsystems. Anal Biochem 107:220–239
Neal DE, Mellon K (1992) Epidermal growth factor receptor and bladder cancer: a review. Urol Int 48:365–371
Ozawa S, Ueda M, Ando N, Abe O, Shimizu N (1987) High incidence of EGF receptor hyperproduction in esophageal squamous cell carcinomas. Int J Cancer 39:333–337
Pekonen F, Partanen S, Rutanen EM (1989) Binding of epidermal growth factor and insulin-like growth factor I in renal carcinoma and adjacent normal kidney tissue. Int J Cancer 43:1029–1033
Sainsbury JRC, Sherbert GV, Farndon JR, Harris AL (1985) Epidermal growth factor receptors and oestrogen receptors in human breast cancer. Lancet I:364–366
Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ, Harris AL (1987) Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1:1398–1402
Westermark K, Karlsson FA, Westermark B (1983) Epidermal growth factor modulates thyroid growth and function in culture. Endocrinology 112:1680–1686
Author information
Authors and Affiliations
Additional information
Dedicated to Prof. Dr. G. Paumgartner on the occasion of his 60th birthday
Rights and permissions
About this article
Cite this article
Saller, B., Stapfer, G., Bein, B. et al. Increased binding capacity of receptors for the epidermal growth factor in benign thyroid nodules and thyroid malignancies. Clin Investig 71, 898–902 (1993). https://doi.org/10.1007/BF00185600
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00185600